UCB to build €300M biologics plant, add 150 workers

UCB, which recently pulled off a $2.5 billion deal for an autoimmune drug candidate, says it sees the need for more biopharma production. To fill it, it will build a €300 million ($333 million) facility and staff it with 150 new workers.